Skip to main content
OpenTrials
Completed

NCT Number: NCT03396159

Validity of Mini Fluid Challenge Post Liver Transplantation

our study aim to assess the validity of using mini fluid challenge to assess the volaemic status of patients after liver transplantation

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Kasr Alainy Hospital , Faculty of Medicine

Cairo, Egypt

About this study

After approval of institutional ethical committee and after informed patient consent, patients fulfilling criteria will be involved. Upon ICU admission, patients will be connected to full monitoring and confirming patient hemodynamic stability and no active bleeding through drains. Patients will be in supine position and baseline readings will be recorded. Fluid responsiveness will be assessed with mini fluid challenge by 150 ml of albumin 5% given over 1 minute. After fluid administration stroke volume (SV) assessed by trans thoracic echo (TTE) and other hemodynamic parameters will be recorded. Remaining 350 ml of albumin 5% will be continued over 14 minute to have total volume given 500 ml. after fluid administration SV and other parameters will be recorded. The fluid challenge will be given intravenously via a specific wide pore venous line. Fluid responsiveness will be defined as an increase in the SV by 15% after the infusion of fluid.

TT Echo Examination:

A single LVOT diameter will be measured for each patient as the distance between the inflection points at the base of the aortic valve cusps from the left parasternal long axis view during systole.

Assuming a circular cross section, the LVOT area will be calculated from the LVOT diameter as:

π X (LVOT diameter/ 2)2 = (LVOT diameter)2 X 0.785 Pulse wave Doppler sampling cursor will be placed in the middle of the LVOT immediately proximal to the aortic valve in 5 chamber apical view.

The sonographer manually will trace the velocity-time envelope (VTI). SV values will be calculated by multiplying VTI by cross sectional area.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients post liver transplantation.
  • ASA III- IV
  • Age > 18 years

Exclusion criteria

  • Age less than 18 years.
  • Patient with fulminant liver failure.

Treatment and study plan

mini fluid challenge

Diagnostic Test

mini fluid challenge will be given to diagnose if patient is need fluid resuscitation or not

Primary outcomes

  1. stroke volume

    Time frame: 1 minute after mini fluid administration

    assessed by trans thoracic echo

Secondary outcomes

  1. heart rate

    Time frame: baseline 10 minutes after intensive care admission, 1 minute after mini fluid challenge and 1 minute after 500 ml of fluid administration

  2. stroke volume

    Time frame: baseline 10 minutes after intensive care admission and 1 minute after 500 ml of fluid administration

    assessed by trans thoracic echo

  3. mean arterial blood pressure

    Time frame: baseline 10 minutes after intensive care admission and 1 minute after 500 ml of fluid administration

Sponsors and collaborators

Lead sponsor

Kasr El Aini Hospital

Other

Registry information

Official study title

Validity of Mini Fluid Challenge to Assess Fluid Responsiveness Post Liver Transplantation

Important dates

Study start
2018
Primary completion
2018
Study completion
2018
First posted
Jan 10, 2018
Registry last updated
Jul 23, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.